Strong Growth Winds Meet Execution Hurdles
India's Electronics Manufacturing Services (EMS) industry is on a strong growth forecast, with analysts projecting a 20-30% compound annual growth rate (CAGR) over the next few years. This expansion is driven by government initiatives such as Production Linked Incentive (PLI) schemes, particularly for large-scale electronics manufacturing (LSEM) and electronic components manufacturing, alongside the 'China+1' supply chain diversification strategy adopted by global Original Equipment Manufacturers (OEMs). These tailwinds have boosted domestic value addition and attracted substantial investment, driving electronics exports to become the third-largest export category.
Analysts Pick Syrma SGS Amid Mixed Stock Fortunes
While the sector's growth narrative remains intact, stock performance and analyst sentiment have diverged, creating a notable split. HDFC Securities has identified Syrma SGS Technology as its top pick in the sector, assigning a 'Buy' rating with a target price of ₹920, anticipating revenue and profit CAGRs of 29% and 44% respectively from FY26-28E. JPMorgan shares this positive view, reiterating an 'Overweight' rating on Syrma SGS with a ₹1,050 price target, suggesting a 44% upside and calling it a "cleaner way to play EMS" due to its lack of cyclical business areas and robust performance. Syrma SGS has also reported strong Q3 FY26 results, with revenue up 45% year-on-year and net profit surging 107%, alongside strategic moves like the Elcome acquisition and PCB manufacturing joint ventures.
Other leading EMS players, however, have faced significant market pressure. Kaynes Technology, despite strong order books and growth prospects, saw its stock experience a significant correction in 2025 due to high valuations and missed earnings expectations. Dixon Technologies also faced corrections in 2025, partly due to concerns over possible earnings per share (EPS) estimate cuts for FY27 and delays in joint venture approvals, though it continues to be a key player in mobile manufacturing and component expansion. Amber Enterprises, while diversified, also faces scrutiny on its high P/E multiples, despite strategic expansion and government scheme benefits.
Valuations Scrutinized as Sector Matures
The Indian EMS sector's valuation multiples are a key focus for investors. Key players like Kaynes Technology trade at price-to-earnings (P/E) ratios between 57x and 98x, while Syrma SGS is at 52x-71x, Dixon at 34x-65x, and Amber Enterprises at 101x-162x, with analysts like Jefferies noting 39x for Syrma, 65x for Kaynes, 70x for Dixon, and 42x for Amber. JPMorgan cautions that while growth is expected to exceed 20% for most players (excluding Dixon) through FY26-28, elevated valuations require clear profitability improvements in 2026. The sector is undergoing a shift from assembling finished goods to manufacturing higher-value components and Printed Circuit Boards (PCBs), a transition where companies like Syrma SGS, Amber Enterprises, and Kaynes Technology are actively investing, often using government incentives like ECMS.
Risks and Challenges for EMS Players
Despite the overarching positive sector outlook, significant risks persist. Kaynes Technology's sharp stock correction in 2025 was driven by high valuations and revised revenue forecasts, alongside slower growth in its industrial segment. Dixon Technologies faces challenges including awaiting regulatory approval for its joint venture with Vivo and potential market saturation in smartphones, potentially affecting medium-term growth. For all players, reliance on imported components remains a significant risk, and rising input costs, as indicated by the recent slowdown in India's manufacturing PMI, could squeeze margins. Furthermore, substantial capital spending on backward integration and new capabilities, though vital for long-term growth, may keep near-term Return on Capital Employed (RoCE) figures steady until utilization increases. Analysts from JP Morgan have also flagged that continued stock gains depend on companies showing better profitability in 2026.
Sector Outlook Remains Positive
Analysts are largely optimistic for the EMS sector, with Motilal Oswal predicting a 30% CAGR in total revenue for their covered companies from FY25-28. JPMorgan expects revenue growth above 20% for most EMS companies through FY26-28. While analysts widely favor Syrma SGS for its strategic position and growth potential, investors will closely watch how well all players execute and maintain margins as they navigate industry changes and economic pressures.